Published in Inflamm Res on October 05, 2010
Macrophage and T cell produced IL-10 promotes viral chronicity. PLoS Pathog (2013) 0.98
IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence. PLoS Pathog (2012) 0.94
RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge. J Virol (2013) 0.92
IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection. J Immunol (2011) 0.90
Infection-induced IL-10 and JAK-STAT: A review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes. JAKSTAT (2012) 0.88
Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy. Glia (2013) 0.87
Differential responses of disease-resistant and disease-susceptible primate macrophages and myeloid dendritic cells to simian hemorrhagic fever virus infection. J Virol (2013) 0.85
IL-10 mediated regulation of liver inflammation during acute murine cytomegalovirus infection. PLoS One (2012) 0.82
Cytomegalovirus Antibody Elevation in Bipolar Disorder: Relation to Elevated Mood States. Neural Plast (2015) 0.77
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology (1982) 11.24
Interleukin-10 determines viral clearance or persistence in vivo. Nat Med (2006) 8.01
Anti-inflammatory cytokines. Chest (2000) 4.74
Biological properties of interleukin 10. Immunol Today (1992) 3.62
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest (1994) 3.12
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med (1994) 2.70
Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum (1996) 1.87
Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med (2009) 1.72
Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol (2003) 1.60
Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J Virol (1991) 1.55
Dysregulated cytokine responses during cytomegalovirus infection in renal transplant recipients. Transplantation (2008) 1.55
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest (1998) 1.40
Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation (2003) 1.37
IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. Eur J Immunol (1998) 1.33
Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J Immunol (1994) 1.29
The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology (1998) 1.28
IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol (2004) 1.28
CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection. J Virol (2006) 1.27
Cytomegalovirus and lung transplantation. Am J Transplant (2004) 1.17
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant (2000) 1.14
IL-10 gene therapy is therapeutic for dextran sodium sulfate-induced murine colitis. Dig Dis Sci (2004) 1.11
The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10. J Immunol (2001) 1.09
CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J Virol (2003) 1.08
Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus. Clin Exp Immunol (2007) 1.04
The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients. J Infect Dis (2000) 1.03
Treatment of experimental viral myocarditis with interleukin-10. Circulation (1999) 1.01
Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection. J Virol Methods (2005) 1.00
Dysregulated interferon-gamma responses during lethal cytomegalovirus brain infection of IL-10-deficient mice. Virus Res (2007) 1.00
Role of interferon-gamma in murine cytomegalovirus infection. J Lab Clin Med (1998) 0.93
Interleukin 10 and arthritis. Rheumatology (Oxford) (1999) 0.91
Cytokine mRNA levels in isolated feline monocytes. Vet Immunol Immunopathol (2001) 0.87
The role of tumor necrosis factor-alpha in acute murine cytomegalovirus infection in BALB/c mice. J Infect Dis (1994) 0.85
Usefulness of interleukin-10 detection in lung transplant patients with human cytomegalovirus infection with respect to virus persistence. Transplantation (2007) 0.84
Reduced lymphocyte infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice. J Neurovirol (2009) 0.83
In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis. Cardiovasc Pathol (2009) 0.79
The impact of donor cytokine gene polymorphisms on the incidence of cytomegalovirus infection after kidney transplantation. Transpl Immunol (2006) 0.77
Interleukin-10 modulation of alloreactivity and graft-versus-host reactions. Transplantation (2002) 0.77
Regulated interleukin-10 expression prevents chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg (2003) 0.77
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Abnormal conduction and morphology in the atrioventricular node of mice with atrioventricular canal targeted deletion of Alk3/Bmpr1a receptor. Circulation (2007) 2.93
Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis. Circ Res (2005) 2.44
Leptin in anorexia nervosa and bulimia nervosa: importance of assay technique and method of interpretation. J Lab Clin Med (2002) 1.43
Poppers: epidemiology and clinical management of inhaled nitrite abuse. Pharmacotherapy (2004) 1.42
The diagnostic utility of cell blocks prepared from residual SurePath Pap material for detection of human papilloma virus. Appl Immunohistochem Mol Morphol (2009) 1.39
Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men. Top HIV Med (2003) 1.32
Consequences of cardiac myocyte-specific ablation of KATP channels in transgenic mice expressing dominant negative Kir6 subunits. Am J Physiol Heart Circ Physiol (2006) 1.22
Sex differences in adverse reactions to antiretroviral drugs. Top HIV Med (2003) 1.17
Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection. AIDS Patient Care STDS (2002) 1.17
Related to ubiquitin 1 and 2 are redundant and essential and regulate vegetative growth, auxin signaling, and ethylene production in Arabidopsis. Plant Cell (2004) 1.15
Creating the future biomedical research workforce. Sci Transl Med (2011) 1.10
Connexin40 imparts conduction heterogeneity to atrial tissue. Circ Res (2008) 1.06
Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection. J Virol Methods (2005) 1.00
Prioritizing health disparities in medical education to improve care. Ann N Y Acad Sci (2013) 0.98
Murine natural killer cell licensing and regulation by T regulatory cells in viral responses. Proc Natl Acad Sci U S A (2013) 0.93
Results of an antimicrobial control program at a university hospital. Am J Health Syst Pharm (2005) 0.93
Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses. Blood (2013) 0.92
Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy. Ann Thorac Surg (2010) 0.91
A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progression. Virus Res (2005) 0.84
Concurrent use of antiretrovirals and anticonvulsants in human immunodeficiency virus (HIV) seropositive patients. Curr Pharm Des (2003) 0.84
Murine cytomegalovirus (MCMV) infection upregulates P38 MAP kinase in aortas of Apo E KO mice: a molecular mechanism for MCMV-induced acceleration of atherosclerosis. J Cardiovasc Transl Res (2012) 0.83
Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance. J Immunol (2013) 0.82
In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis. Cardiovasc Pathol (2009) 0.79
Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patients. Biol Blood Marrow Transplant (2004) 0.77
Paradoxical response to prophylactic Didox (N-3, 4 trihydroxybenzamide) treatment in murine cytomegalovirus-infected mice. Antivir Ther (2011) 0.76
The office of student wellness: innovating to improve student mental health. Acad Psychiatry (2014) 0.76
Restructuring academic health centers to advance interdisciplinary collaborations: opportunities for psychiatry departments. Acad Psychiatry (2013) 0.75
A transparent oversight policy for human anatomical specimen management: the University of California, Davis experience. Acad Med (2014) 0.75
Academia's Gender Problem. Sci Am (2016) 0.75
Licensing delineates helper and effector NK cell subsets during viral infection. JCI Insight (2017) 0.75